Skip to main content
Welcome
Register
Survey
Login Required
Download the App
My Experience
Login Required
People
Oral Presenters
Poster Presenters
Delegrates
Login Required
Schedule
Daily Schedule
Wednesday, November 13, 2024
Thursday, November 14, 2024
Friday, November 15, 2024
Saturday, November 16, 2024
Primary Author
Title
Posters
Primary Author
Number
Title
Category
Poster Galley
Login Required
Poster Award Winners
Sponsors
Sponor Events
Visit Our Sponsors
Thank You Sponsors
Sunrise Mentorship Program
CTOS Networking Events
Networking Events
Welcome Reception
Gala
Ancillary Events
Patient Advocacy
About SPAGN
SPAGN Events
Printable Material
Schedule at a Glance
Oral Presentations
Login Required
Poster Presentations
Login Required
Hotel
Booking Link
Hotel FAQ's
Statement of Conduct
FAQ
Toggle navigation
Login
Search
Home
Welcome
Register
Survey
Login Required
Download the App
My Experience
Login Required
People
Oral Presenters
Poster Presenters
Delegrates
Login Required
Schedule
Daily Schedule
Wednesday, November 13, 2024
Thursday, November 14, 2024
Friday, November 15, 2024
Saturday, November 16, 2024
Primary Author
Title
Posters
Primary Author
Number
Title
Category
Poster Galley
Login Required
Poster Award Winners
Sponsors
Sponor Events
Visit Our Sponsors
Thank You Sponsors
Sunrise Mentorship Program
CTOS Networking Events
Networking Events
Welcome Reception
Gala
Ancillary Events
Patient Advocacy
About SPAGN
SPAGN Events
Printable Material
Schedule at a Glance
Oral Presentations
Login Required
Poster Presentations
Login Required
Hotel
Booking Link
Hotel FAQ's
Statement of Conduct
FAQ
Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Tweet
Print
Damon Reed, MD
Memorial Sloan Kettering
Poster(s):
(P 49) A WORKING GROUP FOR THE DEVELOPMENT OF A CLINICAL FRAMEWORK THAT STRATIFIES OSTEOSARCOMA PATIENTS USING BIOMARKERS OF CLINICAL RISK AND BIOLOGY
(P 50) ANALYSIS OF CLINICAL FEATURES AND OUTCOMES FOR PATIENTS WITH MULTIFOCAL OSTEOSARCOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
(P 113) METASTATIC EWING'S TRAIL TESTING SCHEDULE ENHANCEMENT TO IMPROVE OUTCOMES (METTSEO)
(P 309) PHASE II TRIAL OF GEMCITABINE AND NAB-PACLITAXEL IN PATIENTS WITH RECURRENT SOFT TISSUE SARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
(P 421) CHARACTERIZATION OF INTRA-PATIENT, INTER-LESIONAL RESPONSE AND RESISTANCE DYNAMICS IN METASTATIC, FUSION-POSITIVE RHABDOMYOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Back to Top